Alcohol abuse and alcoholism: an overview.
Alcoholism and alcohol abuse rank among the top 3 psychiatric disorders in the United States. These disorders are associated with significant medical and economic consequences. Furthermore, studies consistently show that an investment in addiction treatment leads to overall cost savings for society. Recent work has identified specific effects of alcohol on several neurotransmitter systems, including gamma-aminobutyric acid, serotonin, dopamine, and the opioid receptors. These findings suggest that multiple pharmacologic interventions may be useful for the treatment of alcohol addiction. This article reviews the clinical use of naltrexone and discusses psychosocial programs to enhance treatment retention and adherence.
Volpicelli
J R
JR
Penn/VA Center for Study of Addiction, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, USA.
D019973:Alcohol-Related Disorders / Q000188:drug therapy* / Q000191:economics / Q000453:epidemiology; D000437:Alcoholism / Q000188:drug therapy* / Q000191:economics / Q000453:epidemiology; D001294:Attitude to Health; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D017046:Cost Savings; D005260:Female; D017048:Health Care Costs; D006801:Humans; D008297:Male; D009271:Naltrexone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D010349:Patient Compliance; D015995:Prevalence; D013240:Stereotyping; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D009292:Narcotic Antagonists; D009271:Naltrexone